Publication date: Jul 29, 2026
The presence of SARS-CoV-2 RNA in blood has been proposed as a marker of severe COVID-19, but it is unclear whether RNAemia mediates the pathway toward worsening disease. We hypothesized that RNAemia is associated with severe disease and distinct gene expression patterns are associated with RNAemia and severe COVID-19. These RNAemia-associated patterns may identify COVID-19 treatment targets. We analyzed 202 hospitalized COVID-19 participants from a multi-center U. S. Military Health System cohort using digital droplet PCR (ddPCR) to quantify SARS-CoV-2 RNA in plasma and performed host RNA sequencing of peripheral blood. Differential gene expression (DGE) logistic regression models were used to assess associations among RNAemia, host gene expression, and disease severity. RNAemia was detected in 39. 1% of participants and was associated with severe disease (54% vs. 32% in RNAemia-negative participants; p
| Concepts | Keywords |
|---|---|
| Biomarkers | |
| COVID-19 | |
| Disease severity | |
| Host response | |
| RNA sequencing | |
| RNAemia | |
| SARS-CoV-2 | |
| Transcriptomics |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |